Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects

NCT01066962 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

800

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: darunavir/ritonavir QD + raltegravir BID
DRUG: darunavir/r QD + tenofovir/emtricitabine QD (fixed dose combination)

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]